Pacific Biosciences of California, Inc. (PACB) Stock Price

PACBStock

$1.40+5.26%52W

Market Cap$435.16M

P/E—

PEG Ratio—

Div yield—

Beta2.33

PACB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-27.59%

Price vs S&P 500 (4W)-2.95%

VGM Score44.91

Book Value / Share (Quarterly)$0.01

P/TBV (Annual)4.28x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.64%

Cash Flow / Share (Quarterly)$-0.42

Price vs S&P 500 (YTD)-37.95%

Gross Margin (TTM)39.20%

Net Profit Margin (TTM)-82.49%

EPS (TTM)$-0.43

10-Day Avg Trading Volume7.51M

EPS Excl Extra (TTM)$-0.43

Revenue Growth (5Y)15.19%

EPS (Annual)$-1.82

ROI (Annual)-83.96%

Gross Margin (Annual)31.22%

Net Profit Margin (5Y Avg)-215.87%

Cash / Share (Quarterly)$0.76

Revenue Growth QoQ (YoY)-1.91%

ROA (Last FY)-69.68%

Revenue Growth TTM (YoY)2.02%

EBITD / Share (TTM)$-0.43

ROE (5Y Avg)-2079.63%

Operating Margin (TTM)-83.53%

Cash Flow / Share (Annual)$-0.39

P/B Ratio151.08x

P/B Ratio (Quarterly)168.49x

Net Income / Employee (Annual)$-1,126,500

EV / Revenue (TTM)5.91x

Net Interest Coverage (TTM)-77.52x

ROA (TTM)-16.84%

EV / EBITDA (TTM)27.64x

EPS Incl Extra (Annual)$-1.82

Current Ratio (Annual)5.15x

Quick Ratio (Quarterly)3.90x

3-Month Avg Trading Volume6.62M

52-Week Price Return5.26%

Revenue / Employee (TTM)$328,400

Tangible BV / Share (Quarterly)$0.07

P/S Ratio (Annual)2.23x

Asset Turnover (Annual)0.20x

52-Week High$2.73

Operating Margin (5Y Avg)-232.44%

EPS Excl Extra (Annual)$-1.82

CapEx CAGR (5Y)49.30%

26-Week Price Return-15.66%

Quick Ratio (Annual)4.32x

13-Week Price Return-4.76%

Total Debt / Equity (Annual)120.65x

Current Ratio (Quarterly)4.92x

Enterprise Value$940.78M

Revenue / Share Growth (5Y)3.42%

Asset Turnover (TTM)0.20x

Book Value / Share Growth (5Y)-60.07%

Revenue / Employee (Annual)$329,900

Inventory Turnover (Annual)2.04x

Pretax Margin (Annual)-341.28%

Cash / Share (Annual)$0.93

3-Month Return Std Dev89.50%

Gross Margin (5Y Avg)34.06%

Net Income / Employee (TTM)$-270,900

ROE (Last FY)-10214.54%

Net Interest Coverage (Annual)-16.81x

EPS Basic Excl Extra (Annual)$-1.82

Receivables Turnover (TTM)5.03x

Total Debt / Equity (Quarterly)272.23x

EPS Incl Extra (TTM)$-0.43

Receivables Turnover (Annual)5.08x

ROI (TTM)-19.14%

P/S Ratio (TTM)2.24x

Pretax Margin (5Y Avg)-231.29%

Revenue / Share (Annual)$0.53

Tangible BV / Share (Annual)$0.40

Price vs S&P 500 (52W)-13.30%

Year-to-Date Return-25.13%

5-Day Price Return9.38%

EPS Normalized (Annual)$-1.82

ROA (5Y Avg)-27.73%

Net Profit Margin (Annual)-341.47%

Month-to-Date Return0.00%

Cash Flow / Share (TTM)$-1.22

EBITD / Share (Annual)$-1.83

Operating Margin (Annual)-346.15%

LT Debt / Equity (Annual)120.65x

ROI (5Y Avg)-32.46%

LT Debt / Equity (Quarterly)272.23x

EPS Basic Excl Extra (TTM)$-0.43

P/TBV (Quarterly)19.27x

P/B Ratio (Annual)105.55x

Inventory Turnover (TTM)1.69x

Pretax Margin (TTM)-81.97%

Book Value / Share (Annual)$0.02

Price vs S&P 500 (13W)-6.72%

Beta2.33x

P/FCF (Annual)19.36x

Revenue / Share (TTM)$0.51

ROE (TTM)-488.45%

52-Week Low$1.07

vGradeD

gGradeC

mGradeC

vgmGradeC

PACB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.13	-$0.14	-10.41%(-$0.01)
Q1 2026	May 7, 2026	-$0.13	-$0.12	+8.70%(+$0.01)
Q4 2025	Feb 12, 2026	-$0.13	-$0.12	+10.77%(+$0.01)
Q3 2025	Nov 5, 2025	-$0.14	-$0.12	+15.11%(+$0.02)
Q2 2025	Aug 7, 2025	-$0.17	-$0.13	+21.53%(+$0.04)

PACB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.75

3.80

3.86

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
PACBPacific Biosciences of California, Inc.	D	C	C	$1.40
AAgilent Technologies Inc.	D	C	B	$153.84
WATWaters Corp	D	C	B	$414.69
ILMNIllumina Inc	D	D	A	$215.59
MTDMettler-Toledo International	D	C	B	$1398.58
RVTYRevvity, Inc.	C	D	A	$128.80
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$387.70
AVTRAvantor, Inc.	B	F	A	$14.58
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$57.08
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$61.54
ALMRAlamar Biosciences, Inc. Common Stock	—	—	B	$30.71
CTKBCytek Biosciences, Inc. Common Stock	C	C	B	$4.68
MASS908 Devices Inc. Common Stock	C	C	B	$10.73
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$25.76
EYPTEyePoint, Inc. Common Stock	D	F	F	$4.48
LABStandard BioTools Inc. Common Stock	A	F	D	$0.64
QTRXQuanterix Corporation Common Stock	A	C	D	$2.64
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.89
SEERSeer, Inc. Class A Common Stock	C	D	C	$1.98
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.57
PRPOPrecipio, Inc. Common Stock	C	A	B	$28.85
HBIOHarvard Bioscience Inc	B	F	A	$7.93
ASTCAstrotech Corporation (DE) Common Stock	C	C	C	$7.15
BNGOBionano Genomics, Inc. Common Stock	A	C	D	$1.17
HLTHTema Healthcare AI ETF	—	F	F	$28.54
PRENWPrenetics Global Limited Warrant	—	—	F	$0.01

About Pacific Biosciences of California, Inc.

Pacific Biosciences develops and manufactures DNA sequencing platforms that enable genetic analysis for research and clinical applications. The company's integrated technology helps scientists and clinical researchers identify and resolve complex genetic problems. Revenue is generated primarily from the Americas, with significant contributions from Europe, the Middle East, Africa, and Asia-Pacific.